Jazz Pharmaceuticals Showcases Evidence Reinforcing Epidiolex (CBD) Medical Benefits

The pharmaceutical company presented data for cannabis-based medicine’s broad-spectrum efficacy in treatment-resistant epilepsies.

Comments

  • No comments yet.
  • Add a comment